| Financial Year |
March 31 2023 |
| Monetary Funds |
226,537,905.01 |
| Held-for-trading Financial Assets |
313,471,074.45 |
| Notes Receivable |
29,972,174.42 |
| Accounts Receivable |
261,426,530.16 |
| Advances to Suppliers |
1,926,410.05 |
| Other Receivables |
4,572,694.08 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
123,002,145.20 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
16,076,352.12 |
| Total Current Assets |
982,135,182.28 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
482,611,797.32 |
| Under-construction Projects |
65,113,887.70 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
77,026,306.83 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
37,556,373.44 |
| Deferred Income Tax Assets |
6,668,149.47 |
| Other Non-Current Assets |
8,261,835.47 |
| Sub-Total of Non-Current Assets |
677,238,350.23 |
| Total Assets |
1,659,373,532.51 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
46,397,207.71 |
| Accounts Payable |
193,084,752.71 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
27,686,210.22 |
| Taxes Payable |
20,930,727.66 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
46,215.44 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
3,626,346.68 |
| Other Current Liabilities |
19,856,472.77 |
| Sub-Total of Current Liabilities |
312,002,477.27 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
48,066,742.69 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
68,377,464.48 |
| Total Liabilities |
380,379,941.75 |
| Paid-In Capital(Or Share Stock) |
101,930,760.00 |
| Capital Surplus |
548,000,248.46 |
| Surplus Reserve |
50,965,380.00 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
578,034,586.08 |
| Minority Stockholder's Interest |
62,616.22 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,278,930,974.54 |
| Owner's Equity（Stockholder's Equity） |
1,278,993,590.76 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,659,373,532.51 |
